These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3330722)

  • 21. Pharmacological basis of drug therapy of Alzheimer's disease.
    Sharma A; Parikh V; Singh M
    Indian J Exp Biol; 1997 Nov; 35(11):1146-55. PubMed ID: 9567741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological replacement of cholinergic function in Alzheimer disease.
    Giacobini E
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():412A-413A. PubMed ID: 1498895
    [No Abstract]   [Full Text] [Related]  

  • 24. The cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ
    J Clin Psychiatry; 1998; 59 Suppl 13():19-22. PubMed ID: 9771826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholinergic and glutamatergic drugs in Alzheimer's disease therapy.
    Clarke NA; Francis PT
    Expert Rev Neurother; 2005 Sep; 5(5):671-82. PubMed ID: 16162091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The medicinal chemistry of Alzheimer's and Alzheimer-like diseases with emphasis on the cholinergic hypothesis.
    Gualtieri F; Dei S; Manetti D; Romanelli MN; Scapecchi S; Teodori E
    Farmaco; 1995; 50(7-8):489-503. PubMed ID: 7669187
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholinergic markers in the early diagnosis of Alzheimer's disease.
    Jenden DJ
    Bull Clin Neurosci; 1985; 50():49-52. PubMed ID: 3915951
    [No Abstract]   [Full Text] [Related]  

  • 28. Recent advances in the treatment of Alzheimer's.
    Richter RW; Farlow MR
    J Okla State Med Assoc; 1998 Nov; 91(8):431-7. PubMed ID: 9828525
    [No Abstract]   [Full Text] [Related]  

  • 29. Alzheimer's disease: cognitive and behavioral pharmacotherapy.
    Cummings JL; Mendez MF
    Conn Med; 1997 Sep; 61(9):543-52. PubMed ID: 9334509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NGF and the treatment of Alzheimer's disease.
    Olson L
    Exp Neurol; 1993 Nov; 124(1):5-15. PubMed ID: 8282080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease.
    Davis R; Raby C; Callahan MJ; Lipinski W; Schwarz R; Dudley DT; Lauffer D; Reece P; Jaen J; Tecle H
    Prog Brain Res; 1993; 98():439-45. PubMed ID: 8248534
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cholinomimetic drugs for Alzheimer's disease?].
    Coria F
    Neurologia; 1995 May; 10(5):187-8. PubMed ID: 7619534
    [No Abstract]   [Full Text] [Related]  

  • 33. Neurotransmitter replacement therapy in Alzheimer's disease.
    Mohr E; Mendis T; Rusk IN; Grimes JD
    J Psychiatry Neurosci; 1994 Jan; 19(1):17-23. PubMed ID: 7908537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The cholinergic perspectives in the treatment of Alzheimer's disease: tacrine].
    Royuela Rico A; Macías Fernández JA
    Rev Clin Esp; 1995 Jul; 195(7):473-8. PubMed ID: 7667523
    [No Abstract]   [Full Text] [Related]  

  • 35. Cholinergic drug studies in dementia and depression.
    Newhouse PA
    Adv Exp Med Biol; 1990; 282():65-76. PubMed ID: 2088086
    [No Abstract]   [Full Text] [Related]  

  • 36. Drugs for treatment of Alzheimer's disease.
    Wilkinson D
    Int J Clin Pract; 2001 Mar; 55(2):129-34. PubMed ID: 11321852
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treating Alzheimer's disease with cholinergic drugs, Part I.
    Terpstra T; Terpstra T
    Nurse Pract; 1998 Nov; 23(11):90, 92, 97 passim. PubMed ID: 9834506
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacologic management of Alzheimer's disease.
    Kumar V; Durai NB; Jobe T
    Clin Geriatr Med; 1998 Feb; 14(1):129-46. PubMed ID: 9456339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Psychopharmacology of noncognitive abnormal behaviors in Alzheimer's disease.
    Raskind MA
    J Clin Psychiatry; 1998; 59 Suppl 9():28-32. PubMed ID: 9720484
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
    Grossberg GT; Edwards KR; Zhao Q
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.